Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test

AIDS

Volumn 11, Issue 3, 1997, Pages

  Dodt, Karen Kaae ^a   Jacobsen, Palle Høy ^b   Hofmann, Bo ^a   Meyer, Christian ^b   Kolmos, Hans J ^a   Skinhøj, Peter ^a   Norrild, Bodil ^c   Mathiesen, Lars ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

AIDS; Antigenemia test; Cytomegalovirus; HIV; Opportunistic infections; Polymerase chain reaction

Indexed keywords

CD4 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SINGLE BLIND PROCEDURE; T LYMPHOCYTE;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS RETINITIS; DNA, VIRAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS;

EID: 0031032821     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199703110-00001     Document Type: Article

References (46)

1. Spector SA, McKinly GF, Lalezari JP, et al.: Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. New Engl J Med 1996, 334:1491-1497.
2. Mills JM: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988. 108:585-594.
3. Jabs DA, Green WR, Fox R, Polk BF, Bartlet JG: Ocular manifestations of acquired immune deficiency syndrome Opthalomology 1989, 96:1092-1099.
4. Bloom JN, Palestine AG: The diagnosis of cytomegalovirus retinitis. Ann Intern Med 1988, 109:963-969.
5. Gerna G, Parea M, Percivalle E, et al.: Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 1990, 4:1027-1031.
6. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical trials Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl Med 1992, 326:213-220.
7. Jacobson MA, Kramer J, Bassiakos Y, et al.: Randomized Phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical trials group protocol 151. J Infect Dis 1994, 170:189-193.
8. Jacobson MA, O'Donnell JJ Porteous D, Brodie HR, leigal D Mills J: Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy. Quart J Med 1988, 254:473-486.
9. Holland GN Sison RE, Jaulis DI, UCIA Retinopathy Study Group: Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. Ophthalmology 1990, 97:204-211.
10. Polis MA, DeSmet MD, Baird BI, et al.: Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received foscarnet. Am J Med 1993, 94:175-180.
11. Gerna G, Zipeto D, Parea M, et al.: Monitoring of human cytomegalovirus infection and ganciclovir treatment in heart transplant recipients by determination of viraemia, antigenemia, and DNAemia. J Infect Dis 1991, 164:488-498.
12. Spector SA: Diagnosis of cytomegalovirus infection. Semin Hematol 1990, 275:11-16.
13. Van Der Bij W, Schirm J, Torensma R, Van Son WJ. Tegzess AM. The TH: Comparison between viraemia and antigenemia for detection of cytomegalovirus in blood J Clin Microbiol 1988 26:2531-2535.
14. Ehrnst A: The clinical relevance of different laboratory tests in CMV diagnosis. Scand J Infect Dis 1996, suppl 100:64-71.
15. Hansen KK, Richsten A, Hofmann B, Norrild B, Olofsson S, Mathiesen L: Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS J Infect Dis 1994, 170:1271-1274.
16. Wirgart BZ, Claesson K, Friksson BM, Tufveson G. Totterman I. Grillner L: CMV pp65 antigen detection in leukocytes compared to CMV DNA amplification from plasma for early diagnosis of CMV infection in kidney transplanted patients. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Edited by Michelson S, Plotkin SA. Amsterdam: Elsevier Science; 1993:195-199.
17. Chou S: Molecular diagnostic techniques for CMV infection. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Edited by Michelson S, Plotkin SA. Amsterdam: Elsevier Science: 1993:183-193.
18. Patel R. Smith TF. Espv M, et al.: A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis 1995, 171:1010-1014.
19. Ehrnst A, Einsele H: Towards standardization of CMV DNA PCR assays. Scand J Infect Dis 1995. suppl 99:16-18.
20. Spector SA, Merrill R, Wolf D, Dankner WM: Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992, 30:2359-2365.
21. Spector SA, Wolf D. Salunga R: Human cytomegalovirus (HCMV) DNA detected in plasma by PCR predicts development of HCMV disease in patients with AIDS or following transplantation. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Edited by Michelson s, plotkin SA. Amsterdam: Elsevier Science: 1993:225-230.
22. Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM. Arnheim N: Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus J Infect Dis 1988, 158:1185-1192.
23. Van der BiJ W, Schirm J, Torensma R, Van Son WJ, Tegzess AM. The T: Comparison between viraemia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1989, 48:814-818.
24. Meyer-Konig U, Serr A, von Laer D. et al.: Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. J Infect Dis 1995 171:6607-6613.
25. Revallo MG, Percivalle L, Zavalloni M, Parea M, Grossi P, Gerna G Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viraemia in immunocompromised patients. J Med Virol 1989, 29:88-93.
26. Van der Bij W. Toreensma R, van Son WJ, et al.: Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal staining of blood leukocytes. J Med Virol 1988, 25:179-188.
27. Bein G, Bitsch A, Hover J, kuchner H: The detection of human cytomegalovirus immediate early antigen in peripheral blood leukocytes. J Immunol Methods 1991, 137:173-180
28. Zweygberg-Wirgart B, Hokeberg I, Landquist M. Griliner I: Detection of cytomegalovirus directly in blood leukocytes and evaluation of new monoclonal antibody, AAC10. Setodiag Immunother Infect 1990, 4:419-426.
29. Landry MI, Ferguson D: Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease J Clin Microbiol 1993 31:2851-2856.
30. Ljungman P, Plotkin SA: Workshop on CMV disease: definitions, clinical severity scores and new syndromes. Scand J Infect Dis 1995, 99:87-89.
31. Weber B Hamann A Ritt B Rabenau H, Doerr HW: Comparison of shell vial culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects. Clin Invest 1992, 70:503-507.
32. SAS/SIAI software: the PHREG Procedure. Version 6. Carv: SAS Institute; 1991
33. Jacobson MA, O'Donnell JJ, Porteous D, Brodie HR, Feigal D, Mills J: Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history and response to ganciclovir therapy. Quart J Med 1988. New Series 67; 254:473-486.
34. Drew WJ: Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992, 14:608-615.
35. Saltzman RL, Quirk MR, Jordan MC : Disseminated cytomegalovirus infection. J Clin Invest 1988, 81:75-81.
36. Roarty JD, Fisher FJ, Nussbaum JJ: Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1993, 100:1685-1688.
37. Bower M, Barton SE, Nelson MK, et al.: The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia. AIDS 1990, 4:317-320.
38. Zurlo JJ. Agnail D, Poles MA, et al.: Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Int Med 1993, 118:12-17.
39. The I, van der Plague M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992, 54:193-198.
40. Lazzarotto I, Dal Monte P, Buccuni MC, Ripalti A, Landini MP: Lack of correlation between virus detection and serological tests for diagnosis of active cytomegalovirus infection in patients with AIDS. J Clin Microbiol 1992, 30:1027-1029.
41. Weber B, Braun W, Cinail J, Doerr HW: Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens. Clin Invest 1993, 71:270-276.
42. The I, van der Berg AP, van Son WJ, et al.: Recent advances in the early and reliable immunodiagnosis of cytomegalovirus infection in immunocompromised hosts. In Progress in Cytomegalovirus Research Edited by Landini MP. Amsterdam: Elsevier; 1991:209.
43. Drew WL, Ives D, Lalezari JP, et al.: Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. New Engl J Med 1995, 333:515-620.
44. The Oral Ganciclovir European and Australian Cooperative Study Group: Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 1995, 9:471-477.
45. I jungman P: Cytomegalovirus infections in transplant patients Scand J Infect Dis 1996, 100:59-63.
46. Einsele H, Ehninger G, Herbart H, et al.: Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995, 86:2815-2820.